Breaking News

Investigators identified mutation, expression, and methylation differences in colorectal polyps from individuals with or without colorectal cancer.

The bill aims to reduce barriers to the use of genetic and genomic testing, including for children on Medicaid with a suspected genetic disease.

LGC Acquires Lucigen

London-based LGC said that the acquisition increases its exposure to the next-generation sequencing and gene editing markets.

The test is based on the company's GARD platform for measuring genetic biomarkers of immune reactions to predict chemical sensitivities.

Among Flatiron's assets is a database developed in collaboration with Foundation Medicine intended to help biopharma firms develop more effective cancer therapies.

A family-based analysis led to an X chromosome variant in MAGEC3 that appeared to contribute to early-onset ovarian cancer risk in sisters and their paternal grandmothers.

An Institut Pasteur-Paris-led team analyzed genetic variants among individuals with classic dengue fever or dengue shock syndrome.

The investment bank gave the company's stock an Outperform rating with a target price of $90 per share.

Whitehead Institute researchers were able to restore nearly full FMR1 expression in a fragile X syndrome iPSC cell line.

An analysis of several multigene breast cancer recurrence signatures suggests that some tests may be better than others at assessing risk of late distant recurrence.

Through a genome-wide association study and meta-analysis, researchers saw dozens of new and known blood pressure loci, including ancestry-specific associations.

The company offers a range of tumor profiling products including the OncoDeep solid tumor test and the OncoTrace liquid biopsy test.

Genetic Technologies and Blockchain Global may partner to develop medical and biotechnology applications that combine their respective technologies.

The firm cited "strong demand for pathology products and companion diagnostics services" for revenue gains in its Diagnostics and Genomics Group.

California Kids Cancer Comparison leader David Haussler said the project's workflow was able to match 100 percent of tumor samples it tested to possible treatments.

An analysis of metagenomic sequences from donor and recipient stool samples highlighted bacterial abundance, phylogeny, and strain features influencing engraftment.

Research on phages in CRISPR-Cas9-containing Escherichia coli indicated that pressure exerted by the bacterial defense system can boost phage mutation frequency.

The company said it would use the funding to continue development of its human microbiome research kits, protocols, and software.

Funded projects will will take advantage of molecular platforms that enable large-scale, robust, and reproducible analysis of transcriptional, epigenomic, proteomic, and metabolomic states.

The company issued more than 1.8 million shares of its common stock to several of its trade creditors to erase debt that it owed them, Precipio said in an SEC document.

The test reduces hands-on time by enabling labs to simultaneously assess Factor II and Factor V gene mutations from a single patient sample, Roche said.

An international team of researchers analyzed the transcriptomes of post-mortem tissue samples to find transcriptional changes.


Under a proposed spending bill, the US National Institutes of Health would see an additional $3 billion in funding.

Researchers from the University of Oxford and the University of Sydney sequenced numerous platypus genomes to study their population history.

Robert Redfield, the new pick to lead the US Centers for Disease Control and Prevention, has faced criticism for some of his work.

In Nature this week: sequenced genomes of five additional Neanderthals, and more.